Rotavirus immunity in the mouse

Archives of Virology, Supplement

Volumn 1996, Issue 12, 1996, Pages 141-152

  Franco, M A ^a   Feng, N ^a   Greenberg, H B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DISEASE MODEL; HUMAN; IMMUNOLOGY; MOUSE; REVIEW; ROTAVIRUS; VACCINATION; VIRUS INFECTION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; ROTAVIRUS; ROTAVIRUS INFECTIONS; VACCINATION;

EID: 1842639258     PISSN: 09391983     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-7091-6553-9_16     Document Type: Article

References (36)

1. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA 273: 1191-1196
2. Bruce MG, Campbell I, Xiong Y, Redmond M, Snodgrass DR (1994) Recognition of rotavirus antigens by mouse L3T4-positive T helper cells. J Gen Virol: 1859-1866
3. Burns JW, Krishnaney AA, Vo PT, Rouse RV, Anderson LJ, Greenberg HB (1995) Analyses of homologous rotavirus infection in the mouse model. Virology 207: 143-153
4. H locus. International Immunol 5: 647-656
5. Dharakul T, Rott L, Greenberg H (1990) Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J Virol 64: 4375-4382
6. Dunn SJ, Burns JW, Cross TL, Vo PT, Bremont M, Greenberg HB (1994) Comparisons of VP4 and VP7 of five murine rotavirus strains. Virology 203: 250-259
7. Dunn SJ, Fiore L, Werner RL, Cross TL, Broome RL, Ruggeri FM, Greenberg HB (1995) Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus. Arch Virol 140: 1969-1978
8. Eiden J, Lederman HM, Vonderfecht S, Yolken R (1986) T-cell-deficient mice display normal recovery from experimental rotavirus infection. J Virol 57: 706-708
9. Eydelloth RS, Vonderfecht SL, Sheridan JF, Enders LD, Yolken RH (1984) Kinetics of viral replication and local and systemic immune response in experimental rotavirus infection. J Virol 50: 947-950
10. Feng N, Burns JW, Bracy L, Greenberg H (1994) Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol 68: 7776-7773
11. Fiore L, Dunn SJ, Ridolfi B, Ruggeri FM, Mackow ER, Greenberg HB (1995) Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus. J Gen Virol: 1981-1988
12. Franco MA, Greenberg HB (1995) Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol 69: 7800-7806
13. Franco MA, Lefevre P, Willems P, Tosser G, Lintermanns P, Cohen J (1994) Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins. J Gen Virol 75: 589-596
14. Franco MA, Prieto I, Labbe M, Poncet D, Borras CF, Cohen J (1993) An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide. J Gen Virol 74: 2579-2586
15. Glass RI, Gentsch J, Smith JC (1994) Rotavirus vaccines: success by reassortment? Science 265: 1389-1391
16. Greenberg HB, Vo PT, Jones R (1986) Cultivation and characterization of three strains of murine rotavirus. J Virol 57: 585-590
17. Ho M, Glass RI, Pinsky PF, Anderson L (1988) Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J Infect Dis 158: 1112-1116
18. Institute of Medicine (1986) New vaccine development. Establishing priorities. Diseases of importance in developing countries, vol II. National Academy Press, Washington DC, pp 308-318
19. Kapikian AZ, Chanock RM (1996) Rotaviruses. In: Fields BN, Knipe DM, Howley PM (eds) Fields Virology, vol 2. Lippincott-Raven, Philadelphia, pp 1657-1708
20. Mackow ER, Vo PT, Broome R, Bass D, Greenberg HB (1990) Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol 64: 1698-1703
21. Matsui SM, Offit PA, Vo PT, Mackow ER, Benfield DA, Shaw RD, Padilla NL, Greenberg HB (1989) Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol 27: 780-782
22. McNeal MM, Sheridan JF, Ward RL (1992) Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology 191: 150-157
23. Offit PA, Boyle DB, Both GW, Hill NL, Svoboda YM, Cunningham SL, Jenkins RJ, McCrae MA (1991) Outer capsid glycoprotein VP7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytes. Virology 184: 563-568
24. Offit PA, Clark HF (1985) Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol 54: 58-64
25. Offit PA, Cunningham SL, Dudzik KJ (1991) Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J Virol 65: 1318-1324
26. Offit PA, Dudzik KI (1989) Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J Virol 63: 3507-3512
27. Offit PA, Dudzik KI (1990) Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J Virol 64: 6325-6328
28. Offit PA, Shaw RD, Greenberg HB (1986) Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins VP3 and VP7. J Virol 58: 700-703
29. Ramig RF (1988) The effects of host age, virus dose, and virus strain on heterologous rotavirus infection of suckling mice. Microb Pathog 4: 189-202
30. Riepenhoff-Talty M, Dharakul T, Kowalski E, Michalak S, Ogra PL (1987) Persistent rotavirus infection in mice with severe combined immunodeficiency. J Virol 61: 3345-3348
31. Sereno MM, Gorziglia MI (1994) The outer capsid protein VP4 of murine rotavirus strain Eb represents a tentative new P type. Virology 199: 500-504
32. Shaw RD, Merchant AA, Groene WS, Cheng EH (1993) Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year. J Clin Microbiol 31: 188-191
33. Ushijima H, Morikawa S, Hasegawa A, Mukoyama A, Suzuki E, Yamamoto T, Nishio O (1995) Characterization of VP4 and VP7 of murine rotavirus (YR-1) Isolated in Japan. Fifth international symposium on double stranded RNA viruses. Abstract P 08
34. Ward RL, McNeal MM, Sheridan JF (1990) Development of an adult mouse model for studies on protection against rotavirus. J Virol 64: 5070-5075
35. Wolf JL, Cukor G, Blacklow NR, Dambrauskas R, Trier JS (1981) Susceptibility of mice to rotavirus infection: effects of age and administration of corticosteriods. Infect Immun 33: 565-574
36. Woode GN, Zheng S, Melendy DR, Ramig RF (1989) Studies on rotavirus homologous and heterologous active immunity in infant mice. Viral Immunol 2: 127-132